Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Mar 9:17:1085589.
doi: 10.3389/fnins.2023.1085589. eCollection 2023.

Maternal ART throughout gestation prevents caudate volume reductions in neonates who are HIV exposed but uninfected

Affiliations

Maternal ART throughout gestation prevents caudate volume reductions in neonates who are HIV exposed but uninfected

Abdulmumin Ibrahim et al. Front Neurosci. .

Abstract

Introduction: Successful programmes for prevention of vertical HIV transmission have reduced the risk of infant HIV infection in South Africa from 8% in 2008 to below 1% in 2018/2019, resulting in an increasing population of children exposed to HIV perinatally but who are uninfected (HEU). However, the long-term effects of HIV and antiretroviral treatment (ART) exposure on the developing brain are not well understood. Whereas children who are HEU perform better than their HIV-infected counterparts, they demonstrate greater neurodevelopmental delay than children who are HIV unexposed and uninfected (HUU), especially in resource-poor settings. Here we investigate subcortical volumetric differences related to HIV and ART exposure in neonates.

Methods: We included 120 infants (59 girls; 79 HEU) born to healthy women with and without HIV infection in Cape Town, South Africa, where HIV sero-prevalence approaches 30%. Of the 79 HEU infants, 40 were exposed to ART throughout gestation (i.e., mothers initiated ART pre conception; HEU-pre), and 39 were exposed to ART for part of gestation (i.e., mothers initiated ART post conception; HEU-post). Post-conception mothers had a mean (± SD) gestational age (GA) of 15.4 (± 5.7) weeks at ART initiation. Mothers with HIV received standard care fixed drug combination ART (Tenofovir/Efavirenz/Emtricitabine). Infants were imaged unsedated on a 3T Skyra (Siemens, Erlangen, Germany) at mean GA equivalent of 41.5 (± 1.0) weeks. Selected regions (caudate, putamen, pallidum, thalamus, cerebellar hemispheres and vermis, and corpus callosum) were manually traced on T1-weighted images using Freeview.

Results: HEU neonates had smaller left putamen volumes than HUU [β (SE) = -90.3 (45.3), p = 0.05] and caudate volume reductions that depended on ART exposure duration in utero. While the HEU-pre group demonstrated no caudate volume reductions compared to HUU, the HEU-post group had smaller caudate volumes bilaterally [β (SE) = -145.5 (45.1), p = 0.002, and -135.7 (49.7), p = 0.008 for left and right caudate, respectively].

Discussion: These findings from the first postnatal month suggest that maternal ART throughout gestation is protective to the caudate nuclei. In contrast, left putamens were smaller across all HEU newborns, despite maternal ART.

Keywords: HIV exposure; antiretroviral therapy; brain structure; magnetic resonance imaging; neonate; neurodevelopment.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

FIGURE 1
FIGURE 1
Flow diagram showing maternal and infant participant and exclusion numbers at each stage of the study.
FIGURE 2
FIGURE 2
Representative T1-weighted brain MR images from one neonate without HIV exposure or infection (HUU), showing the manually segmented structures of the basal ganglia [caudate (sky blue), putamen (magenta), pallidum (dark blue)], thalamus (green), cerebellar hemispheres (yellow), and cerebellar vermis (purple). Images are in coronal view (slices 80-96 and 112-124).
FIGURE 3
FIGURE 3
Comparison of regional volumes by group. The HEU group comprised infants who were HIV-exposed but uninfected born to mothers who had either initiated ART pre-conception (HEU-pre) or during gestation (post-conception; HEU-post); HUU are infants who were not HIV-exposed or infected. Hourglasses show median and interquartile ranges; whiskers are upper and lower extremes. Values above and below the whiskers are outliers, defined as data points more than 1.5 times the interquartile range above (or below) the upper (or lower) quartile. p values from independent one-tail student t-tests.
FIGURE 4
FIGURE 4
Plots showing associations of regional volumes with maternal clinical and treatment variables among infants who were HIV-exposed but uninfected. All associations shown remained significant after control for potential confounding variables.

References

    1. Abu-Raya B., Kollmann T. R., Marchant A., MacGillivray D. M. (2016). The immune system of HIV-exposed uninfected infants. Front. Immunol. 7:383. 10.3389/fimmu.2016.00383 - DOI - PMC - PubMed
    1. Agabu A., Baughman A. L., Fischer-Walker C., de Klerk M., Mutenda N., Rusberg F., et al. (2020). National-level effectiveness of ART to prevent early mother to child transmission of HIV in Namibia. PLoS One 15:e0233341. 10.1371/journal.pone.0233341 - DOI - PMC - PubMed
    1. Alcaide M. L., Rodriguez V. J., Abbamonte J. M., Ramlagan S., Sifunda S., Weiss S. M., et al. (2019). Maternal factors associated with infant neurodevelopment in HIV-exposed uninfected infants. Open Forum Infect. Dis. 6:ofz351. 10.1093/ofid/ofz351 - DOI - PMC - PubMed
    1. Alcock K. J., Abubakar A., Newton C. R., Holding P. (2016). The effects of prenatal HIV exposure on language functioning in Kenyan children: Establishing an evaluative framework. BMC Res. Notes 9:463. 10.1186/s13104-016-2264-3 - DOI - PMC - PubMed
    1. Alimenti A., Forbes J. C., Oberlander T. F., Money D. M., Grunau R. E., Papsdorf M. P., et al. (2006). A prospective controlled study of neurodevelopment in HIV-uninfected children exposed to combination antiretroviral drugs in pregnancy. Pediatrics 118 e1139–e1145. 10.1542/peds.2006-0525 - DOI - PubMed

LinkOut - more resources